Christina Cho, Rhiannon Kelsh-Lasher, Anthony Ambesi, Paula J McKeown-Longo
{"title":"Cryptic activity within the Type III<sub>1</sub> domain of fibronectin regulates tissue inflammation and angiogenesis.","authors":"Christina Cho, Rhiannon Kelsh-Lasher, Anthony Ambesi, Paula J McKeown-Longo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The fibronectin matrix provides mechanical and biochemical information to regulate homeostatic and pathological processes within tissues. Fibronectin consists of independently-folded modules termed Types I, II and III. In response to cellular contractile force, Type III domains unfold to initiate a series of homophilic binding events which result in the assembly of a complex network of intertwining fibrils. The unfolding of Type III modules provides elasticity to the assembled fibronectin matrix allowing it to function as a dynamic scaffold which provides binding sites for cellular receptors, growth factors and other matrix molecules. Access to bioactive sites within the fibronectin matrix is under complex regulation and controlled through a combination of mechanical and proteolytic activity. Mechanical unfolding of Type III modules and limited proteolysis can alter the topographical display of bioactive sites within the fibronectin fibrils by exposing previously cryptic sites and disrupting functional sites. In this review we will discuss cryptic activity found within the first Type III module of fibronectin and its impact on tissue angiogenesis and inflammation.</p>","PeriodicalId":39897,"journal":{"name":"Current Topics in Peptide and Protein Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981920/pdf/nihms-806346.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Topics in Peptide and Protein Research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0
Abstract
The fibronectin matrix provides mechanical and biochemical information to regulate homeostatic and pathological processes within tissues. Fibronectin consists of independently-folded modules termed Types I, II and III. In response to cellular contractile force, Type III domains unfold to initiate a series of homophilic binding events which result in the assembly of a complex network of intertwining fibrils. The unfolding of Type III modules provides elasticity to the assembled fibronectin matrix allowing it to function as a dynamic scaffold which provides binding sites for cellular receptors, growth factors and other matrix molecules. Access to bioactive sites within the fibronectin matrix is under complex regulation and controlled through a combination of mechanical and proteolytic activity. Mechanical unfolding of Type III modules and limited proteolysis can alter the topographical display of bioactive sites within the fibronectin fibrils by exposing previously cryptic sites and disrupting functional sites. In this review we will discuss cryptic activity found within the first Type III module of fibronectin and its impact on tissue angiogenesis and inflammation.
纤维粘连蛋白基质提供机械和生化信息,以调节组织内的平衡和病理过程。纤连蛋白由独立折叠的 I、II 和 III 型模块组成。在细胞收缩力的作用下,III 型结构域展开,启动一系列嗜同结合事件,从而形成复杂的交织纤维网络。III 型模块的展开为组装好的纤连蛋白基质提供了弹性,使其能够发挥动态支架的功能,为细胞受体、生长因子和其他基质分子提供结合位点。纤连蛋白基质中生物活性位点的获取受到复杂的调节,并通过机械和蛋白水解活性的组合进行控制。III 型模块的机械展开和有限的蛋白水解可通过暴露以前的隐蔽位点和破坏功能位点来改变纤维粘连蛋白纤维内生物活性位点的地形显示。在本综述中,我们将讨论在纤维粘连蛋白第一个 III 型模块中发现的隐性活性及其对组织血管生成和炎症的影响。
期刊介绍:
Current Topics in Peptide & Protein Research provides a medium for the publication of review articles and original research papers on various aspects of peptide and protein Research. It covers all aspects of amino acid, peptide, peptidomimetic, and protein science, including chemical, biophysical, biological and pharmaceutical aspects.